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Recently, Misinzo et al. (G. Misinzo, P. Meerts, M. Bublot, J. Mast, H. M. Weingartl, and H. J. Nauwynck, J. Gen.
Virol. 86:2057–2068, 2005) reported that inhibiting endosome-lysosome system acidification reduced porcine cir-
covirus 2 (PCV2) infection of monocytic 3D4/31 cells. The present study examined the effect of inhibiting endosome-
lysosome system acidification in epithelial cells, since epithelial cells support PCV2 infection in vivo and are used
in culturing PCV2 in vitro. Ammonium chloride (NH4Cl), chloroquine diphosphate (CQ), and monensin were used
to inhibit endosome-lysosome system acidification. NH4Cl, CQ, or monensin increased PCV2 (Stoon-1010) infection
by 726% 110%, 1,212% 34%, and 1,100% 179%, respectively, in porcine kidney (PK-15) cells; by 128% 7%,
158% 3%, and 142% 11% in swine kidney cells; by 160% 28%, 446% 50%, and 162% 56% in swine testicle
(ST) cells; and by 313%  25%, 611%  86%, and 352%  44% in primary kidney epithelial cells. Similarly,
increased PCV2 infection was observed with six other PCV2 strains in PK-15 cells treated with endosome-lysosome
system acidification inhibitors. The mechanism behind increased PCV2 infection was further investigated in PK-15
cells using CQ. PCV2 infection of PK-15 cells was increased only when CQ was added early during PCV2 infection.
CQ did not affect PCV2 virus-like particle (VLP) attachment to PK-15 cells but increased the disassembly of
internalized PCV2 VLPs. In untreated PK-15 cells, internalized PCV2 VLPs localized within the endosome-lysosome
system. PCV2 infection of untreated 3D4/31 and PK-15 cells and CQ-treated PK-15 cells was blocked by a serine
protease inhibitor [4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride] but not by aspartyl protease (pep-
statin A), cysteine protease (E-64), and metalloprotease (phosphoramidon) inhibitors. These results suggest that
serine protease-mediated PCV2 disassembly is enhanced in porcine epithelial cells but inhibited in monocytic cells
after inhibition of endosome-lysosome system acidification.
Porcine circovirus 2 (PCV2) is a member of the family Cir-
coviridae. PCV2 has a circular single-stranded DNA genome of
1,768 bases in which open reading frame 1 (ORF1) encodes
replication-associated proteins (Rep and Rep), ORF2 en-
codes a capsid protein, and ORF3 encodes a 105-amino-acid
protein (9, 34, 52, 54). PCV2 infection is associated with post-
weaning multisystemic wasting syndrome (PMWS), a multifac-
torial disease in weaned pigs characterized by severe growth
retardation, rapid weight loss, and high mortality rates in af-
fected pigs (13, 20, 52). High PCV2 replication has been found
to be associated with the development of PMWS and has thus
been included as a criterion in the case definition of PMWS
(61). In PCV2-positive swine herds and experimentally PCV2-
inoculated pigs, only a small proportion of pigs experience high
PCV2 replication and subsequently develop severe clinical
signs or PMWS (33, 55, 59). The identification of factors that
predispose individual pigs to high PCV2 replication compared
to other pigs within the same herd is important in understand-
ing the pathogenesis of PMWS. Some host-specific factors that
influence the level of PCV2 replication in pigs have already
been identified. The absence of PCV2-neutralizing antibodies
(44); a general stimulation of the immune system arising from
concurrent infections, vaccination, or concanavalin A treat-
ment (3, 31, 32, 43, 56); and/or immunosuppression (30, 47)
may predispose pigs to persistent high PCV2 replication and
development of PMWS.
The susceptibilities of different cell types to PCV2 infection
depend on the age of the fetus or the piglet (59). The differ-
ential susceptibilities of cells have been linked to mitosis, since
PCV2 does not encode its own DNA polymerase and requires
active cellular polymerases for viral replication (59). Treat-
ment of cells in vitro with either glucosamine or gamma inter-
feron increases PCV1 and PCV2 infection, respectively (46,
66). However, another factor(s) or mechanism(s) that explains
the specific tropisms and differential susceptibilities of target
cells to PCV2 infections may be involved. Misinzo et al. (51)
showed that the susceptibility of the 3D4/31 monocytic-cell line
to PCV2 infection was reduced following inhibition of endo-
some-lysosome system acidification, suggesting that an acidic
environment is necessary for PCV2 infection. Generalization
of this finding to other cell types is not possible. For instance,
inhibition of endosome-lysosome system acidification inhibits
human immunodeficiency virus type 1 (HIV-1) replication in
primary T cells and monocytes, as well as T-cell and monocytic-
cell lines (62), whereas it increases HIV-1 infectivity in human
293T and HeLa Magi cells (16).
Epithelial cells support PCV2 replication in pigs experimen-
tally infected with PCV2, as well as in pigs with naturally
occurring PCV2-associated PMWS (23, 57). In addition, PCV2
replicates and is cultivated in vitro in porcine kidney (PK-15)
(2, 42) and swine kidney (SK) epithelial-cell lines (58). Until
now, no study has investigated the effect of inhibiting endo-
some-lysosome system acidification on PCV2 infection of
PCV2 target cells other than the monocytic-cell line 3D4/31.
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The aim of this study was to investigate the importance of
endosome-lysosome system acidification on PCV2 infection of
epithelial cells.
MATERIALS AND METHODS
Cells, virus, and PCV2 virus-like particles (VLP). PK-15, SK, and swine
testicle (ST) epithelial-cell lines and a 3D4/31 monocytic-cell line free from
porcine circoviruses were used. Cells were seeded at 2  105/ml and maintained
in culture medium containing 10% fetal bovine serum (FBS) (Invitrogen, Grand
Island, MI), 0.3 mg/ml L-glutamine (BDH Chemicals, Ltd., Poole, England), 1%
nonessential amino acids (100; Invitrogen), 1 mM sodium pyruvate (Invitro-
gen), 100 U/ml penicillin, 0.1 mg/ml streptomycin, and 0.1 mg/ml kanamycin in
RPMI 1640 (Invitrogen).
Primary porcine kidney epithelial cells were obtained by trypsinization of the
kidney cortices from three 3-week-old PCV2-negative conventional piglets. The
kidney cortices were dissected from the medullas after the removal of the kidney
capsule, minced, and incubated in phosphate-buffered saline (PBS) containing
2.5 mg/ml trypsin (Sigma, Bornem, Belgium) at 37°C for 10 min. The trypsiniza-
tion of the minced kidney cortices was done twice. After each trypsinization,
primary kidney cells were collected by sieving them through three-layered cotton
gauze. The cells were pelleted by centrifugation and resuspended at 2  105/ml
in Dulbecco’s modified Eagle medium (Invitrogen) containing 10% FBS, 0.3
mg/ml L-glutamine, and antibiotics.
The seeded cells were maintained at 37°C in a humidified 5% CO2 incubator.
All experiments were carried out 24 h postseeding, when the cells reached
approximately 50% confluence.
Different PCV2 strains passaged in PK-15 cells, previously described by Meerts et
al. (45), were included in this study. The cells were inoculated with PCV2 strains
Stoon-1010, 1121, 1103, 48285, VC2002, 1206, and 1147 at a multiplicity of infection
of 0.3 for 1 h at 37°C.
Recombinant PCV2 VLP were used for analysis of PCV2 binding, intracellular
localization, and disassembly in PK-15 cells as previously described (50, 51).
Effects of lysosomotropic agents on PCV2 infection of epithelial cells. Endo-
some-lysosome system acidification was inhibited using lysosomotropic weak
bases (ammonium chloride [NH4Cl] and chloroquine diphosphate [CQ]) and the
carboxylic ionophore monensin. NH4Cl, CQ, and monensin are lysosomotropic
agents because they selectively accumulate in lysosomes (12). Apart from inhib-
iting the acidification of the endosome-lysosome system, NH4Cl, CQ, and mo-
nensin decrease intralysosomal proteolysis and cause intracellular vesicular
swelling (10, 14). Therefore, other lysosomotropic agents without an effect on
endosome-lysosome system acidification but that (i) decrease intralysosomal
proteolysis and cause intracellular vesicular swelling (suramin) (1, 26, 27) or (ii)
have no effect on intralysosomal proteolysis and cause intracellular vesicular
swelling (polyvinylpyrrolidone [PVP]) (10, 17, 27) were included. All chemical
compounds were purchased from Sigma.
The highest concentrations for each of the lysosomotropic agents that did not
affect PK-15 cell viability after a 24-h incubation period were used: 25 mM, 125
M, 6 M, 1 mg/ml, and 1 mg/ml of NH4Cl, CQ, monensin, suramin, and PVP,
respectively. PK-15, ST, SK, and primary porcine kidney epithelial cells were
washed once and pretreated or not with lysosomotropic agents for 1 h. The cells
were inoculated with equal doses of PCV2 in the presence or absence of the
lysosomotropic agents. The viral inoculum was washed off, and the cells were
further incubated in culture medium with or without lysosomotropic agents (i)
for 24 h to assess the effect on PCV2 infection or (ii) for different durations to
determine the time points at which the lysosomotropic agents had their effects.
Subsequently, culture medium with or without lysosomotropic agents was re-
placed with culture medium without lysosomotropic agents. After the first cycle
of PCV2 replication, at 36 h postinoculation (p.i.), the cells were fixed with
methanol at 20°C for 10 min.
For epithelial-cell lines, PCV2-infected cells were stained using an immuno-
peroxidase monolayer assay (IPMA) as previously described (50). PCV2-infected
cells were counted by examination under an Olympus light microscope (Olympus
Optical Co., Hamburg, Germany). The number of infected cells per well in
untreated cells was used as a reference, and all results were expressed as a
percentage of this reference.
For primary porcine kidney epithelial cells, a double immunofluorescence
staining was performed to identify epithelial cells and PCV2-infected cells in
primary kidney cell cultures. Kidney epithelial cells were identified with mouse
anti-human cytokeratin monoclonal antibody (clone MNF116; DakoCytomation,
Glostrup, Denmark), followed by incubation with fluorescein isothiocyanate
(FITC)-conjugated goat anti-mouse immunoglobulin G (IgG) (Invitrogen).
PCV2-infected cells in kidney cell cultures were identified by incubation with
biotinylated anti-PCV2 swine antibodies (59), followed by streptavidin-conju-
gated Texas Red (Invitrogen). Each of the staining incubations was carried out
for 1 h at 37°C. Cell nuclei were stained by incubating the cells for 10 min at room
temperature with Hoechst 33342 (Invitrogen) at a concentration of 10 g/ml.
After each of the incubations, the cells were washed with PBS. Finally, the
stained cells were mounted, and analysis of the number of PCV2-infected kidney
epithelial cells per 104 cells was done by using a Leica DM/RBE fluorescence
microscope. The number of infected cells among the untreated cells was used as
a reference, and all results were expressed as a percentage of this reference.
All experiments were performed three times, and each condition in an exper-
iment was performed in quadruplicate.
Effects of inhibiting endosome-lysosome system acidification on PCV2 VLP
attachment and disassembly of internalized PCV2 VLP. PK-15 cells were chilled
on ice and washed with ice-cold RPMI 1640. PCV2 VLP were then added at 4°C
for 1 h in the presence or absence of 125 M CQ to allow binding to PK-15 cells.
Unbound PCV2 VLP were washed off, and the cells were refreshed with either
prewarmed medium without FBS or similar culture medium containing 125 M
CQ. The PK-15 cells were then incubated at 37°C in a humidified 5% CO2
incubator. At 0 and 3 h after the 37°C shift, the cells were fixed in 3% (wt/vol)
paraformaldehyde in PBS containing Ca2 and Mg2 (PBS). A double immu-
nofluorescence staining was performed in order to distinguish bound and inter-
nalized PCV2 VLP. Bound PCV2 VLP were stained using the anti-PCV2 capsid-
specific monoclonal antibody F190 (40), followed by FITC-conjugated goat
anti-mouse IgG. The cells were subsequently washed with PBS and perme-
abilized with Triton X-100 (0.1% in PBS) for 2 min at room temperature. After
permeabilization, all PCV2 VLP were identified using the same monoclonal
antibody F190, followed by Texas Red-conjugated goat anti-mouse IgG (Invitro-
gen). Finally, the cells were mounted and analyzed using a Leica TCS SP2 laser
scanning spectral confocal system linked to a Leica DM/IRB inverted micro-
scope. The total fluorescence area of attached PCV2 VLP in cells treated or not
with CQ was estimated using the image analysis software SigmaScan Pro 5.0 as
previously described (50, 51).
Intracellular localization of internalized PCV2 VLP in PK-15 cells. To identify
the intracellular organelle(s) in which PCV2 VLP localizes, PK-15 cells were
chilled on ice, washed with ice-cold RPMI 1640, and incubated with PCV2 VLP
for 1 h at 4°C. Unbound PCV2 VLP were washed off, and the cells were
refreshed with prewarmed medium without FBS. The PK-15 cells were then
incubated at 37°C in a humidified 5% CO2 incubator for 3 h, after which they
were fixed in 3% (wt/vol) paraformaldehyde in PBS. The cells were subse-
quently washed and permeabilized with Triton X-100 (0.1% in PBS) for 2 min
at room temperature. Intracellular localization of PCV2 VLP was determined by
a double immunofluorescence labeling of internalized PCV2 VLP and early
endosomes, lysosomes, or Golgi apparatus and/or the endoplasmic reticulum.
Early endosomes were labeled using goat polyclonal anti-early endosome antigen
1 (EEA-1) IgG (Santa Cruz Biotechnology, Santa Cruz, CA), the lysosomes were
labeled with goat polyclonal anti-cathepsin D IgG (Santa Cruz Biotechnology),
the Golgi apparatus was labeled using rabbit polyclonal anti-giantin IgG (Euro-
gentec, Seraing, Belgium), and the endoplasmic reticulum was labeled using goat
polyclonal anti-calnexin IgG (Santa Cruz Biotechnology). The cells were then
incubated with Alexa Fluor 594-conjugated rabbit anti-goat (Invitrogen) to rec-
ognize goat polyclonal IgG or Texas Red-conjugated goat anti-rabbit (Invitro-
gen) to recognize rabbit polyclonal IgG. PCV2 VLP were labeled using the
anti-PCV2 capsid-specific monoclonal antibody F190, followed by FITC-conju-
gated goat anti-mouse IgG. The cells were mounted, and images were acquired
by confocal microscopy.
Effects of protease inhibitors on PCV2 infection of CQ-treated PK-15 cells.
The protease inhibitors 4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride
(AEBSF) (which inhibits serine proteases), pepstatin A (which inhibits aspartyl
proteases), trans-epoxysuccinyl-L-leucylamido-(4-guanidino) butane (E-64) (which
inhibits cysteine proteases), and phosphoramidon (which inhibits metalloproteases)
were used to analyze the potential involvement of proteases during PCV2 infection
and to identify the class of cellular protease potentially responsible for PCV2 capsid
disassembly. All protease inhibitors were from Sigma. PK-15 and 3D4/31 cells were
preincubated with or without 0.5 mM or 0.25 mM AEBSF, 1 g/ml pepstatin A, 100
M E-64, or 45 M phosphoramidon for 1 h at 37°C. After 1 h, PK-15 and 3D4/31
cells were inoculated with PCV2 (Stoon-1010) for 1 h at 37°C in the presence or
absence of protease inhibitors. The cells were then washed and incubated for 24 h in
culture medium with or without protease inhibitors containing 125 M CQ for
PK-15 cells and 0 M CQ for 3D4/31 cells. At 24 h p.i., the culture medium with or
without protease inhibitors and CQ was replaced with fresh culture medium. The
cells were fixed at 36 h p.i., and an IPMA staining was performed to identify
PCV2-infected cells. The number of PCV2-infected PK-15 cells among cells treated
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with a combination of a protease inhibitor and CQ was expressed as a percentage of
the number of PCV2-infected cells among cells treated with CQ alone. The number
of PCV2-infected 3D4/31 cells among cells treated with a protease inhibitor was
expressed as a percentage of the number of PCV2-infected cells among untreated
cells.
Effects of protease inhibitors on disassembly of internalized PCV2 VLP in
CQ-treated PK-15 cells. PK-15 cells were preincubated with or without 0.5 mM
AEBSF for 1 h at 37°C. Afterwards, the PK-15 cells were chilled on ice and
washed with ice-cold RPMI 1640. PCV2 VLP were then added at 4°C for 1 h in
the presence of 125 M CQ to allow binding to the PK-15 cells. Unbound PCV2
VLP were washed off, and the cells were refreshed with either prewarmed
medium without FBS or similar culture medium containing 125 M CQ with or
without 0.5 mM AEBSF. The PK-15 cells were then incubated at 37°C in a
humidified 5% CO2 incubator. At 0 and 3 h after the 37°C shift, the cells were
fixed in 3% (wt/vol) paraformaldehyde in PBS. The double immunofluores-
cence staining to distinguish bound and internalized PCV2 VLP, confocal mi-
croscopy, and analysis were performed as described above for the investigation of
the effect of inhibiting endosome-lysosome system acidification on disassembly of
internalized PCV2 VLP.
RESULTS
Inhibiting endosome-lysosome system acidification enhances
the number of PCV2-infected cells among porcine epithelial cells.
The endosome-lysosome system is characterized by gradual
acidification of its vesicles as they mature from early endo-
somes (pH 6.0 to 6.8) into lysosomes (pH 5.0) (48). Endo-
some-lysosome system acidification can be inhibited by some
lysosomotropic agents. Epithelial-cell lines (PK-15, SK, and
ST) and primary porcine kidney epithelial cells were treated
with lysosomotropic agents to investigate the effect of in-
hibiting endosome-lysosome system acidification on PCV2
infection. The effects of different lysosomotropic agents on
PCV2 infection of epithelial cells inoculated with the pro-
totype PCV2 strain Stoon-1010 are shown in Fig. 1 and 2
and Tables 1 and 2. In general, greater increases in the
numbers of PCV2-infected cells were observed in PK-15 and
primary porcine kidney epithelial cells than in SK and ST
cells treated with NH4Cl, CQ, monensin, and suramin (Ta-
ble 2). Treatment of cells with PVP did not increase the
number of PCV2-infected cells in any epithelial-cell type.
Different PCV2 strains were used to investigate if the en-
hancement of PCV2 infection by inhibitors of endosome-lyso-
some system acidification is general in other PCV2 strains.
PCV2 infection was increased in PK-15 cells with all strains
following treatment with NH4Cl, CQ, monensin, and suramin
(Table 3). The magnitudes of the increases of PCV2 infection
following inhibition of endosome-lysosome system acidifica-
tion were different between strains, with PCV2 strain 1103
showing the least increase in the number of infected cells. No
significant increase in the number of PCV2-infected PK-15
cells was found in cells treated with PVP.
CQ treatment of PK-15 cells increases the disassembly of
internalized PCV2 VLP. In order to examine the stage during
the PCV2 replication cycle in which lysosomotropic agents
exert their effects, CQ was added at different time points be-
fore, during, or after PCV2 inoculation, as shown in Fig. 3.
Addition of CQ for 1 h before inoculation, for 1 h during
inoculation, or from 12 h p.i. onward did not increase the
number of PCV2-infected PK-15 cells significantly. However,
addition of CQ during the first 6 hours of PCV2 infection
increased the number of PCV2-infected PK-15 cells signifi-
cantly (Fig. 3). Thus, inhibiting endosome-lysosome system
acidification increases PCV2 infection by affecting an early
stage(s) of PCV2 infection.
The effects of CQ on early stages of PCV2 entry, such as
attachment and disassembly, were further investigated. To ex-
FIG. 1. Effects of lysosomotropic weak bases on PCV2 Stoon-1010
infection of PK-15 cells. PK-15 cells were treated with RPMI 1640
(control), 25 mM NH4Cl, or 125 M CQ from 1 h before virus inoc-
ulation until 24 h after virus inoculation. The cells were inoculated with
the same dose of PCV2 (Stoon-1010) for 1 h. At 36 h after virus
inoculation, the cells were fixed and stained for PCV2 antigens by
IPMA. Magnification, 50.
FIG. 2. PCV2 infection of primary kidney epithelial cells. Primary
kidney cell cultures were obtained by trypsinization of kidney cortices.
After 24 h in culture, the kidney cells were inoculated with PCV2
(Stoon-1010) and further cultured in cell culture medium (A) or cell
culture medium containing 125 M CQ (B). The cells were fixed 36 h
after virus inoculation and analyzed by fluorescence confocal micros-
copy after a double immunofluorescence staining was performed to
visualize epithelial cells (cytokeratin; green fluorescence) and PCV2
antigens (red fluorescence). The susceptibility of primary kidney epi-
thelial cells to PCV2 infection increased following treatment with CQ
(B). Each panel represents an overlay of confocal images taken from
the apex to the base of the cell. Bar, 20 m.
TABLE 1. Effects of lysosomotropic agents on PCV2 (Stoon-1010)
infection of PK-15 cells
Lysosomotropic
agent Concn
% PCV2-infected
cellsa
NH4Cl 25.0 mM 726  110
6.25 mM 540  96
1.56 mM 252  79
CQ 125.0 M 1,212  34
31.25 M 834  169
7.81 M 501  121
Monensin 6 M 1,100  179
1.5 M 859  134
0.375 M 574  24
Suramin 1,000 g/ml 237  29
250 g/ml 184  23
62.5 g/ml 133  28
PVP 1,000 g/ml 73  6
250 g/ml 91  3
62.5 g/ml 95  10
a The percentages of PCV2-infected PK-15 cells following treatment with
lysosomotropic agents are expressed relative to the number of PCV2-infected
cells among untreated PK-15 cells. The data represent means  standard
deviations from three experiments, with each experiment performed in qua-
druplicate.
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amine attachment, PCV2 VLP were allowed to bind to PK-15
cells for 1 h at 4°C in the absence or presence of CQ. The
relative total fluorescences of bound PCV2 VLP in PK-15 cells
treated or not with CQ were 107  22 and 100  20, respec-
tively. In order to examine the effects of endosome-lysosome
system acidification inhibition on PCV2 internalization and
disassembly, cells were incubated with PCV2 VLP for 3 h at
37°C in the absence or presence of CQ. PCV2 VLP were
visible within the cells after 3 h of incubation in untreated cells,
but not in CQ-treated cells (Fig. 4). This observation indicates
that under normal circumstances PCV2 is slowly disassembled
within the cell and that inhibiting endosome-lysosome system
acidification provides an optimal environment that enhances
PCV2 disassembly.
Internalized PCV2 VLP localize within endosome-lysosome
system compartments of PK-15 cells. To allow a better under-
standing of the mechanism by which CQ enhances PCV2 in-
fection, identification of the intracellular compartment in
which PCV2 is transported following internalization was per-
formed. Intracellular localization of PCV2 VLP was deter-
mined using double immunofluorescent labeling for PCV2
VLP and markers of early endosomes, lysosomes, the Golgi
apparatus, and the endoplasmic reticulum. Immunofluorescent
labeling of PCV2 VLP prior to shifting the cells to 37°C dem-
onstrated no colocalization of PCV2 VLP with markers for
early endosome, lysosome, Golgi apparatus, and endoplasmic
reticulum. PCV2 VLP within the cell, 3 h after internalization
(shift to 37°C), colocalized with early endosomes and lyso-
somes, but not with the Golgi apparatus and the endoplasmic
reticulum (Fig. 5).
Proteolytic cleavage of PCV2 capsid is mediated by a cellu-
lar serine protease. Internalized PCV2 VLP disassembled within
TABLE 2. Effects of lysosomotropic agents on infection of the
prototype PCV2 strain Stoon-1010 in PK-15, SK, ST,
and PPKE cells
Cell type
% PCV2-infected cells treated witha:
NH4Cl CQ Monensin Suramin PVP
PK-15 726  110 1,212  34 1,100  179 237  29 73  6
SK 128  7 158  3 142  11 118  3 80  27
ST 160  28 446  50 162  56 117  5 86  17
PPKEb 313  25 611  86 352  44 109  15 90  19
a The numbers of PCV2-infected cells following treatment with lysosomo-
tropic agents are expressed as percentages of the numbers of PCV2-infected cells
among the respective untreated cells. The data represent means  standard
deviations of three experiments, with each experiment performed in quadrupli-
cate.
b PPKE, primary porcine kidney epithelial.
TABLE 3. Effects of lysosomotropic agents on infection of different
PCV2 strains of PK-15 cells
PCV2
strain
% PCV2-infected cells treated witha:
NH4Cl CQ Monensin Suramin PVP
Stoon-1010 726  110 1,212  34 1,100  179 237  29 73  6
1121 1,041  277 1,452  62 752  148 206  24 60  10
1103 138  86 183  151 115  12 128  10 115  9
48285 345  147 856  76 994  119 434  71 102  9
VC2002 340  92 905  150 963  246 271  67 94  20
1206 235  88 446  87 792  206 344  109 95  2
1147 234  88 530  185 457  42 201  46 108  2
a The percentages of PK-15 PCV2-infected cells following treatment with
lysosomotropic agents are expressed relative to the number of PK-15 PCV2-
infected cells among untreated cells. The data represent means  standard
deviations of results from three experiments, with each experimental condition
performed in quadruplicate.
FIG. 3. Effects of CQ at different time points and durations through-
out the PCV2 infection cycle. PK-15 cells were inoculated with the same
dose of PCV2 Stoon-1010 for 1 h (0 to 1 h p.i.), after which the viral
inoculum was washed off. CQ (0 or 125 M) was added at different times
before (b.i.) or after (p.i.) virus inoculation and left with the cells for
different durations, as indicated. After 36 h p.i., the cells were fixed and
stained for PCV2 antigens. The percentages of PCV2-infected PK-15 cells
following CQ treatment are expressed relative to the number of PCV2-
infected PK-15 cells among untreated cells. The data represent means
plus standard deviations of results from three experiments, with each
experimental condition performed in quadruplicate.
FIG. 4. Effects of CQ treatment on PCV2 attachment and internal-
ization. PCV2 VLP were either allowed to bind to PK-15 cells for 1 h at
4°C or further incubated for 3 h at 37°C in the absence or presence of 125
M CQ and then fixed with 3% paraformaldehyde. PCV2 VLP were
stained with F190 monoclonal antibody and FITC-conjugated goat anti-
mouse, followed by permeabilization of the cells. PCV2 VLP were stained
again with F190 and Texas Red-conjugated goat anti-mouse antibodies.
(A to D) Bound PCV2 VLP showed both green and red fluorescence
(yellow), while internalized PCV2 VLP showed only red fluorescence in
merged confocal images of single z sections. Internalized PCV2 VLP were
visible in untreated cells (C), while no PCV2 VLP were visible within the
cell in CQ-treated cells (D), most probably due to increased disassembly
of internalized PCV2 VLP. Bar, 20 m.
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endosome-lysosome system compartments in CQ-treated PK-15
cells. Because disassembly of viruses within the endosome-lyso-
some system can be mediated by proteases, the roles of cellular
proteases in PCV2 infection were investigated. Cellular proteases
are classified into serine, cysteine, and aspartic proteases and
metalloproteases (4). PCV2 infection was completely blocked
when CQ-treated PK-15 cells were incubated with 0.5 mM
AEBSF. Treatment of non-CQ-treated PK-15 cells with 0.5 mM
AEBSF also completely blocked PCV2 infection. The relative
numbers of PCV2-infected cells among CQ-treated PK-15 cells
were 30% 14%, 82% 2%, 84% 3%, and 82% 14% when
they were incubated with 0.25 mM AEBSF, 1 g/ml pepstatin A,
100 M E-64, and 45 M phosphoramidon, respectively. To
investigate if the reductions of infection resulted from an effect on
PCV2 disassembly, the effect of AEBSF on the uncoating of
PCV2 VLP was analyzed. The disassembly of PCV2 VLP ob-
served in CQ-treated PK-15 cells was inhibited by AEBSF. The
accumulation of internalized PCV2 VLP in CQ-treated PK-15
cells treated with AEBSF indicated that the absence of PCV2
VLP within the cell in CQ-treated cells was not a result of CQ
interference with internalization but rather on accelerated disas-
sembly of internalized PCV2 VLP. The effect of inhibiting cellular
protease on PCV2 infection was also investigated in 3D4/31 cells,
in which inhibiting endosome-lysosome system acidification in
monocytic cells reduced PCV2 infection, in contrast to epithelial
cells. PCV2 infection of 3D4/31 cells was also completely blocked
by treatment of the cells with 0.5 mM AEBSF. The relative
numbers of PCV2-infected cells among 3D4/31 cells were 36%
14%, 128% 26%, 70% 10%, and 93% 10% when 3D4/31
cells were incubated with 0.25 mM AEBSF, 1 g/ml pepstatin A,
100 M E-64, and 45 M phosphoramidon, respectively.
DISCUSSION
In the present study, inhibition of endosome-lysosome sys-
tem acidification enhanced PCV2 infection of porcine epithe-
lial cell lines, as well as of primary porcine kidney epithelial
cells. Increased PCV2 infection occurred when endosome-ly-
sosome system acidification was inhibited during early stages of
PCV2 infection. The effects of inhibitors of endosome-lyso-
some system acidification were not at the level of PCV2 capsid
attachment but at the level of PCV2 capsid disassembly of
internalized PCV2. The disassembly of PCV2 capsid was me-
diated by a serine protease.
To our knowledge, the present study is the first to show
enhanced infection of a single-stranded DNA nonenveloped
virus as a result of elevating the pH of the endosome-lysosome
system. The fact that neutralizing the acidic endosome-lyso-
some system enhances PCV2 infection of epithelial cells is in
contrast with numerous studies that have shown that neutral-
izing the acidic endosome-lysosome system inhibits the infec-
tion of pH-dependent nonenveloped viruses (7, 8, 18, 35, 36,
63) and enveloped viruses (21, 38, 64, 65, 70). Inhibiting en-
dosome-lysosome system acidification also inhibits PCV2 in-
fection of 3D4/31 monocytic cells (51), further contrasting the
results presented in this study for epithelial cells. In vitro,
inhibition of endosome-lysosome system acidification has been
shown to increase the infection of enveloped HIV-1 (16, 69).
Most HIV-1 particles are endocytosed (37, 60) and do not
result in productive infection because an acidic environment
within the endosome-lysosome system leads to virus degrada-
tion in lysosomes (15, 37, 60). Inhibition of endosome-lyso-
some system acidification has been suggested to slow down the
proteolytic degradation of endocytosed infectious HIV-1 par-
ticles, thus providing sufficient time for HIV-1 to fuse with
endocytic membranes and deliver virion cores to the cytoplasm
(16). PCV2 is a nonenveloped virus and does not uncoat by
fusion with endocytic membranes. Instead, this study shows
that a serine protease-mediated PCV2 capsid disassembly is
essential for PCV2 uncoating. Several possible scenarios may
explain the enhanced PCV2 infection of epithelial cells result-
ing from elevated pH within the endosome-lysosome system.
First, inhibiting endosome-lysosome system acidification may
provide sufficient time and optimum pH for a serine protease
to disassemble the PCV2 capsid. Inhibiting endosome-lyso-
some system acidification causes all compartments of the en-
dosome-lysosome system to have an “endosome-like” pH. This
“endosome-like” pH is assumed to be optimal for serine pro-
teases that cleave the PCV2 capsid. The inhibitors of endo-
some-lysosome system acidification also inhibit the maturation
of endosomes to lysosomes, further restricting the localization
of internalized PCV2 within endosomes, where optimum
PCV2 capsid cleavage seems to occur. Second, inhibitors of
endosome-lysosome system acidification may directly activate
certain proteases within the endosome-lysosome system (5, 28,
29), which may be responsible for the PCV2 capsid dissasem-
bly. In this way, PCV2 capsid disassembly may be increased.
Third, inhibition of endosome-lysosome system acidification
FIG. 5. Colocalization of internalized PCV2 VLP with cellular or-
ganelles. PCV2 VLP were allowed to bind to PK-15 cells at 4°C for 1 h,
after which the cells were shifted to 37°C to initiate PCV2 VLP inter-
nalization. After 3 h of internalization, the cells were fixed and stained
for PCV2 VLP (green fluorescence) and one of the cellular organelles
(red fluorescence). Representative merged images of PCV2 VLP and
early endosomes (A), lysosomes (B), the Golgi apparatus (C), and the
endoplasmic reticulum (D) after 3 h of internalization are shown. Bar,
20 m.
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alters the sorting of certain proteins (including proteases) that
are normally destined to be transported to the plasma mem-
brane to be directed toward endosome-lysosome system com-
partments (24, 25). If these proteins happen to be proteases
that cleave PCV2 capsid, enhanced PCV2 disassembly may
occur, explaining the observed increase in PCV2 infection.
Fourth, lysosomotropic agents that inhibit endosome-lysosome
system acidification can also cause intracellular vesicular swell-
ing (10, 14, 49), which may result in increased release of en-
docytosed cargo into the cytoplasm. This is unlikely for endo-
cytosed PCV2, since PVP, a lysosomotropic agent with no
effect on endosome-lysosome system acidification but which
causes osmosis-related intracellular vesicular swelling (10, 17,
27), did not affect PCV2 infection. Surprisingly, suramin, which
causes intracellular vesicular swelling and decreases intralyso-
somal proteolysis (7, 8, 26, 27, 29), slightly increased PCV2
infection of epithelial cells. Another suramin activity may be
responsible for the enhanced PCV2 infection, such as the ac-
tivation of DNA synthesis (53, 71), since PCV2 replication is
cell cycle dependent and the stimulation of cellular prolifera-
tion by suramin may help PCV2 to replicate.
PCV2 infects PK-15 and SK porcine epithelial cell lines (2,
40, 42, 58). In this study, a testis-derived epithelial-cell line
(ST) was susceptible to PCV2 infection, showing that epithelial
cells from other organs may also be susceptible to PCV2 in-
fection. PCV2 infects epithelial cells in pigs experimentally
infected with PCV2 (23), in PMWS pigs (13, 57), and in pri-
mary kidney cultures (22), based on histological and morpho-
logical identification. This study confirmed the susceptibility of
primary kidney epithelial cells to PCV2 infection using double
immunofluorescence labeling of PCV2 antigens and cytokera-
tin, an epithelial-cell-specific intermediate filament. The sus-
ceptibility of primary kidney epithelial cells was equal to that
observed in PK-15 cells, suggesting that the latter provide a
good in vitro model for studying PCV2 interactions with epi-
thelial cells. This observation is supported by previous studies
that have reported that PK-15 cells display cellular growth
characteristics similar to those of primary epithelial cells in
culture (11).
This study investigated the effects of inhibiting endosome-
lysosome system acidification on the infection of different
PCV2 strains isolated from cases of PMWS (13, 41, 47), por-
cine dermatitis and nephropathy syndrome (41), or reproduc-
tive failure (41). All PCV2 strains (with the exception of the
1103 strain) showed increased infection upon inhibition of
endosome-lysosome system acidification; however, differences
in magnitude were observed. This indicates that, although a
common PCV2 infection mechanism at the level of disassem-
bly in epithelial cells is shared by PMWS-, porcine dermatitis
and nephropathy syndrome-, and reproductive-failure-associ-
ated PCV2 strains, there are subtle differences that differenti-
ate them. These might arise from differences in amino acid
sequence at a protease cleavage site(s) that may cause the
different susceptibilities of PCV2 capsids to cleavage by a cel-
lular serine protease(s). At this point, these differences cannot
be determined, because the serine protease(s) responsible for
PCV2 capsid disassembly is unknown. Other studies have also
reported differences in the replication kinetics of different
PCV2 strains isolated from distinct PCV2-related diseases
(45). Why the replication of strain 1103 could not be influ-
enced by the inhibitors of endosome-lysosome system acidifi-
cation is not clear. It is possible that the serine protease cleav-
age site is absent in this strain.
PCV2 is internalized via clathrin-mediated endocytosis in
monocytic (51) and dendritic (67) cells. Although the mecha-
nism of PCV2 entry in epithelial cells was not investigated, the
localization of PCV2 in early endosomes in epithelial cells
suggests that PCV2 becomes internalized via a pathway whose
vesicles bud on the early endosome. Proteins endocytosed into
early endosomes can be recycled to the cell surface, trans-
ported to the trans-Golgi network, or routed to late endosomes
and lysosomes (19). Internalized PCV2 was localized in lyso-
somes but not in the trans-Golgi network, indicating that PCV2
was transported from endosomes onto lysosomes. The exact
internalization pathway for PCV2 in epithelial cells remains to
be determined.
The present study showed that a serine protease is also
important in the disassembly of PCV2 in monocytic 3D4/31
cells. Because PCV2 disassembly requires a low pH in 3D4/31
cells and a neutral pH in epithelial cells, it is reasonable to
suggest that two different serine proteases in these cell types
are involved in PCV2 disassembly. Further studies are re-
quired to identify these serine proteases.
PCV2 had been circulating in the pig population for years
before the emergence of PMWS (61). The reason why PMWS
emerged suddenly is still not clear. One may speculate that
drugs that inhibit endosome-lysosome system acidification may
predispose pigs to high PCV2 replication and PMWS. The
carboxylic ionophore monensin has been used for the preven-
tion or treatment of certain porcine diseases, and another
carboxylic ionophore, salinomycin, has been used as a growth
promoter in pigs (6). Whether PCV2 infection can be en-
hanced in pigs, which may result in PMWS, following admin-
istration of endosome-lysosome system acidification inhibitors
in PCV2-infected pigs remains to be investigated. Further,
different human pathophysiological conditions characterized
by failure of endosome-lysosome system acidification, such as
hereditary and acquired forms of the Fanconi syndrome, have
been reported (39, 68). It is not known if such conditions exist
in pigs or, if they exist, whether they predispose pigs to PCV2-
induced PMWS.
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